DPP-IV inhibitors for treating early stages of diabetic retinopathy in an experimental model: a dose-efficacy study

被引：0
|
作者：
Ramos, H. [1 ,2 ]
Bogdanov, P. [1 ,2 ]
Sampedro, J. [1 ,2 ]
Valeri, M. [3 ]
Simo, R. [1 ,2 ]
Hernandez, C. [1 ,2 ]
机构：
[1] Vall dHebron Res Inst, Diabet & Metab Res Unit, Barcelona, Spain
[2] CIBERDEM, Madrid, Spain
[3] Vall dHebron Res Inst, Unit High Technol, Barcelona, Spain
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
827
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 4 条
  • [1] DPP-IV Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model: A Dose-Efficacy Study
    Ramos, H.
    Bogdanov, P.
    Sampedro, J.
    Valeri, M.
    Simo, R.
    Hernandez, C.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (1_SUPPL) : 3 - 4
  • [2] Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
    Bogdanov, Patricia
    Ramos, Hugo
    Valeri, Marta
    Deas-Just, Anna
    Huerta, Jordi
    Simo, Rafael
    Hernandez, Cristina
    BIOMEDICINES, 2022, 10 (02)
  • [3] Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy
    Ramos, Hugo
    Bogdanov, Patricia
    Huerta, Jordi
    Deas-Just, Anna
    Hernandez, Cristina
    Simo, Rafael
    ANTIOXIDANTS, 2022, 11 (07)
  • [4] Efficacy and safety of DPP-IV inhibitors for the treatment of older people with Type 2 diabetes: an observational study
    Viljoen, A.
    Meek, C. L.
    Gadsby, R.
    Viljoen, S.
    Langerman, C.
    Sinclair, A.
    DIABETIC MEDICINE, 2013, 30 : 165 - 165
1